Eche N et al. |
Platelet aggregating and procoagulant activities of cultured human breast cancer cells (FAM). |
1986 |
Thromb. Res. |
pmid:3726808
|
Slattery CW and Beaumont DO |
Sheep platelets as a model for human platelets: evidence for specific PAF (platelet activating factor) receptors. |
1989 |
Thromb. Res. |
pmid:2554526
|
Vargaftig BB et al. |
Adrenaline and PAF-acether synergize to trigger cyclooxygenase-independent activation of plasma-free human platelets. |
1982 |
Thromb. Res. |
pmid:7164036
|
Okamoto M et al. |
Platelet activating factor (PAF) involvement in endotoxin-induced thrombocytopenia in rabbits: studies with FR-900452, a specific inhibitor of PAF. |
1986 |
Thromb. Res. |
pmid:3754990
|
Valone FH |
Inhibition of platelet-activating factor binding to human platelets by calcium channel blockers. |
1987 |
Thromb. Res. |
pmid:3590086
|
Tokumura A et al. |
Platelet aggregation induced by ether-linked phospholipids. 2. Mechanism of desensitization of rabbit platelets by platelet activating factor and reversibility of inhibitory actions of its antagonists. |
1987 |
Thromb. Res. |
pmid:3590110
|
Wade PJ et al. |
Effect of calcium and calcium antagonists on [3H]-Paf-acether binding to washed human platelets. |
1986 |
Thromb. Res. |
pmid:3961730
|
Cox CP and Wood KL |
Selective antagonism of platelet-activating factor (PAF)-induced aggregation and secretion in washed rabbit platelets by CV-3988, L-652731, triazolam and alprazolam. |
1987 |
Thromb. Res. |
pmid:3629553
|
Catalán RE et al. |
Dissociation between secretion and protein phosphorylation in agonist-stimulated platelets; action of PCA-4230, a new antithrombotic drug. |
1994 |
Thromb. Res. |
pmid:7974386
|
Ostermann G et al. |
Plasma from atherosclerotic patients exerts an increased degradation of platelet-activating factor. |
1987 |
Thromb. Res. |
pmid:3629555
|
Hwang SB et al. |
Effects of nonsteroid antiinflammatory drugs on the specific binding of platelet activating factor to membrane preparations of rabbit platelets. |
1984 |
Thromb. Res. |
pmid:6429890
|
Petty AC and Scrutton MC |
Platelet aggregation in whole blood: is the response to adrenaline, 5-hydroxytryptamine and PAF a direct consequence of stimulation by these agonists? |
1989 |
Thromb. Res. |
pmid:2749609
|
Violi F et al. |
Human platelet aggregation by PAF and thromboxane production. |
1987 |
Thromb. Res. |
pmid:3424290
|
Cox CP |
Effects of CV-3988, an antagonist of platelet-activating factor (PAF), on washed rabbit platelets. |
1986 |
Thromb. Res. |
pmid:2421432
|
Nunn B |
Total and selective desensitisation of human platelets to synthetic platelet activating factor (PAF): evidence that extracellular PAF does not mediate collagen-induced aggregation. |
1983 |
Thromb. Res. |
pmid:6648898
|
Vrzheshch PV et al. |
Cell response kinetics: the phenomenon of supercooperativity in aggregation of human platelets. |
1992 |
Thromb. Res. |
pmid:1523610
|
Kohayakawa M and Inoue K |
Augmentation of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF)-induced human platelet activation by C-reactive protein. |
1986 |
Thromb. Res. |
pmid:3083530
|
Despotis GJ et al. |
Effects of platelets and white blood cells and antiplatelet agent C7E3 (Reopro) on a new test of PAF procoagulant activity of whole blood. |
1997 |
Thromb. Res. |
pmid:9175242
|
Küster LJ and Frölich JC |
PAF-induced platelet aggregation and TXB2 formation. |
1989 |
Thromb. Res. |
pmid:2922704
|
Neiman J et al. |
Platelet responses to platelet-activating factor are inhibited in alcoholics undergoing alcohol withdrawal. |
1989 |
Thromb. Res. |
pmid:2617478
|
May JA et al. |
Platelet responses to several agonists and combinations of agonists in whole blood: a placebo controlled comparison of the effects of a once daily dose of plain aspirin 300 mg, plain aspirin 75 mg and enteric coated aspirin 300 mg, in man. |
1997 |
Thromb. Res. |
pmid:9361371
|
Lian EC et al. |
Purification and some properties of a protein obtained from normal human plasma which inhibits the platelet aggregation induced by thrombotic thrombocytopenic purpura plasma. |
1984 |
Thromb. Res. |
pmid:6420930
|
Inoue Y et al. |
Effect of a platelet activating factor antagonist and antithrombin III on septicemia and endotoxemia in rats. |
1991 |
Tohoku J. Exp. Med. |
pmid:2063402
|
Nishihira J et al. |
Purification and characterization of the specific binding protein for platelet activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) from human platelets. |
1985 |
Tohoku J. Exp. Med. |
pmid:3001971
|
Isobe J and Mizuno A |
Aspects of PAF (platelet activating factor)-induced aggregation by using rabbit platelets. |
1982 |
Tokushima J. Exp. Med. |
pmid:7170716
|
Ezoulin MJ et al. |
Study of PMS777, a new type of acetylcholinesterase inhibitor, in human HepG2 cells. Comparison with tacrine and galanthamine on oxidative stress and mitochondrial impairment. |
2006 |
Toxicol In Vitro |
pmid:16472967
|
Baskin SI et al. |
The effects of EDRF/NO releasers or calcium ionophore A23187 on cyanide toxicity in mice. |
1996 |
Toxicol. Appl. Pharmacol. |
pmid:8806852
|
Wright DT et al. |
Ozone stimulates release of platelet activating factor and activates phospholipases in guinea pig tracheal epithelial cells in primary culture. |
1994 |
Toxicol. Appl. Pharmacol. |
pmid:8048050
|
Nomura DK et al. |
Dual roles of brain serine hydrolase KIAA1363 in ether lipid metabolism and organophosphate detoxification. |
2008 |
Toxicol. Appl. Pharmacol. |
pmid:18164358
|
Samet JM and Friedman M |
Effect of ozone on platelet activating factor metabolism in phorbol-differentiated HL60 cells. |
1992 |
Toxicol. Appl. Pharmacol. |
pmid:1440609
|
Hanslik T et al. |
Effect of the platelet activating factor antagonist BN52021 in rabbits: role in gentamicin nephrotoxicity. |
1994 |
Toxicol. Appl. Pharmacol. |
pmid:8079343
|
Ramos G et al. |
Platelet activating factor receptor binding plays a critical role in jet fuel-induced immune suppression. |
2004 |
Toxicol. Appl. Pharmacol. |
pmid:15020195
|
Feuerstein G et al. |
Protective effect of a PAF-acether antagonist, BN 52021, in trichothecene toxicosis. |
1987 |
Toxicol. Lett. |
pmid:3660430
|
Bailie MB et al. |
Platelet activating factor receptor blockade alone or in combination with leukotriene synthesis inhibition does not ameliorate alpha-naphthylisothiocyanate-induced hepatotoxicity. |
1996 |
Toxicol. Lett. |
pmid:8614909
|
Mahgoub AA |
Thymoquinone protects against experimental colitis in rats. |
2003 |
Toxicol. Lett. |
pmid:12749817
|
Flaherty MM et al. |
Nonclinical evaluation of GMA161--an antihuman CD16 (FcγRIII) monoclonal antibody for treatment of autoimmune disorders in CD16 transgenic mice. |
2012 |
Toxicol. Sci. |
pmid:22025730
|
Grandoni KM et al. |
Trichothecene mycotoxins inhibit phosphoinositide hydrolysis in bovine platelets stimulated with platelet activating factor. |
1992 |
Toxicology |
pmid:1311467
|
Pearson JM et al. |
Neither platelet activating factor nor leukotrienes are critical mediators of liver injury after lipopolysaccharide administration. |
1997 |
Toxicology |
pmid:9231696
|
Gambero A et al. |
Signalling pathways regulating human neutrophil migration induced by secretory phospholipases A2. |
2004 |
Toxicon |
pmid:15450921
|
Teixeira CF et al. |
Hyperalgesia induced by Bothrops jararaca venom in rats: role of eicosanoids and platelet activating factor (PAF). |
1994 |
Toxicon |
pmid:8052996
|
Shiroma N et al. |
Haemodynamic and haematologic effects of Acanthaster planci venom in dogs. |
1994 |
Toxicon |
pmid:7846692
|
Havt A et al. |
The renal effects of Bothrops jararacussu venom and the role of PLA(2) and PAF blockers. |
2001 |
Toxicon |
pmid:11600146
|
Castro-Faria-Neto HC et al. |
Pro-inflammatory activity of enterolobin: a haemolytic protein purified from seeds of the Brazilian tree Enterolobium contortisiliquum. |
1991 |
Toxicon |
pmid:1796477
|
Yara A et al. |
Cardiovascular effects of Acanthaster planci venom in the rat: possible involvement of PAF in its hypotensive effect. |
1992 |
Toxicon |
pmid:1440631
|
Rees RS et al. |
Plasma components are required for platelet activation by the toxin of Loxosceles reclusa. |
1988 |
Toxicon |
pmid:3245050
|
Freire-Maia L and de Matos IM |
Heparin or a PAF antagonist (BN-52021) prevents the acute pulmonary edema induced by Tityus serrulatus scorpion venom in the rat. |
1993 |
Toxicon |
pmid:8266352
|
Tai H et al. |
TMVA, a snake C-type lectin-like protein from Trimeresurus mucrosquamatus venom, activates platelet via GPIb. |
2004 |
Toxicon |
pmid:15501291
|
Melo RC et al. |
Intragranular vesiculotubular compartments are involved in piecemeal degranulation by activated human eosinophils. |
2005 |
Traffic |
pmid:16138901
|
Guerrant RL et al. |
Diarrhea, demography and cell signaling: lessons from microbial toxins. |
1997 |
Trans. Am. Clin. Climatol. Assoc. |
pmid:9108674
|
Shukla SD et al. |
Response to platelet-activating factor in human platelets stored and aged in plasma. Decrease in aggregation, phosphoinositide turnover, and receptor affinity. |
1989 Jul-Aug |
Transfusion |
pmid:2546298
|